Effect of pre existing respiratory conditions on survival of lung cancer patients: A nationwide population‐based cohort study

Effect of pre existing respiratory conditions on survival of lung cancer patients: A nationwide... 1INTRODUCTIONLung cancer has been the most commonly diagnosed cancer in the world for several decades. World Health Organization estimated that 1.8 million new lung cancer cases would occur in 2012 (12.9% of all cancer), in the latest GLOBOCAN 2012. The disease remains as the highest prevalent cancer among men globally (1.2 million), with generally lower incidence rates among women. Lung cancer is the most common cause of death for cancer worldwide accounting for nearly, one‐fifth of cancer deaths (1.59 million deaths, 19.4% of the total deaths), with an increasing trend between 2002 and 2008 statistics: 1.4 million deaths (18% of the total) in 2008 and 1.18 million deaths (17.6% of the total) in 2002.Previous research confirmed that lung cancer risk is increasing in the general population including non‐smokers because of factors other than tobacco smoking, which has been traditionally recognized as the most important carcinogenic factor. The proportion of never‐smoking patients with non‐small cell lung cancer (NSCLC) has been increasing over time: 15.9% in the 1970s, 25.8% in the 1980s, 30.4% in the 1990s and 32.8% in the 2000s. Furthermore, the never‐smoking NSCLC group also had higher incidence of adenocarcinoma (87.8%) in comparison to the smoking NSCLC group (49.1%) http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Asia-Pacific Journal of Clinical Oncology Wiley

Effect of pre existing respiratory conditions on survival of lung cancer patients: A nationwide population‐based cohort study

Loading next page...
 
/lp/wiley/effect-of-pre-existing-respiratory-conditions-on-survival-of-lung-fwem5tUtGm
Publisher
Wiley
Copyright
Copyright © 2018 John Wiley & Sons Australia, Ltd
ISSN
1743-7555
eISSN
1743-7563
D.O.I.
10.1111/ajco.12697
Publisher site
See Article on Publisher Site

Abstract

1INTRODUCTIONLung cancer has been the most commonly diagnosed cancer in the world for several decades. World Health Organization estimated that 1.8 million new lung cancer cases would occur in 2012 (12.9% of all cancer), in the latest GLOBOCAN 2012. The disease remains as the highest prevalent cancer among men globally (1.2 million), with generally lower incidence rates among women. Lung cancer is the most common cause of death for cancer worldwide accounting for nearly, one‐fifth of cancer deaths (1.59 million deaths, 19.4% of the total deaths), with an increasing trend between 2002 and 2008 statistics: 1.4 million deaths (18% of the total) in 2008 and 1.18 million deaths (17.6% of the total) in 2002.Previous research confirmed that lung cancer risk is increasing in the general population including non‐smokers because of factors other than tobacco smoking, which has been traditionally recognized as the most important carcinogenic factor. The proportion of never‐smoking patients with non‐small cell lung cancer (NSCLC) has been increasing over time: 15.9% in the 1970s, 25.8% in the 1980s, 30.4% in the 1990s and 32.8% in the 2000s. Furthermore, the never‐smoking NSCLC group also had higher incidence of adenocarcinoma (87.8%) in comparison to the smoking NSCLC group (49.1%)

Journal

Asia-Pacific Journal of Clinical OncologyWiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off